Brief: Pharmaust Seeks Trading Halt
17/08/2023 11:18
Aug 17 (Reuters) - Pharmaust Ltd PAA.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT OF NEUROFILAMENT
LIGHT
CHAIN RESULTS FROM MOTOR NEURONE DISEASE PHASE 1/2 CLINICAL
TRIAL
Source text for Eikon: ID:nASXbZ9zGz
Further company coverage: PAA.AX
(Reporting by Shivangi Lahiri)
((Shivangi.Lahiri@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon Therapeutics jumps on deal with US firm
Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
Brief: Neurizon Therapeutics Receives Ethics Approval For Phase 1 Nuz-001 Oral Liquid Formulation Study
Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO